RxDoctor Payments Data

Brittany James, APRN

Family · Houma, LANPI 1104590843

Payments from drug & device makers

$631in general payments, 2019–2025

Across 33 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$120
  • Otsuka America Pharmaceutical, Inc.$59
  • Vanda Pharmaceuticals Inc.$53
  • Lilly USA, LLC$50
  • AstraZeneca$48
  • Amgen$48
  • plus $253 from 10 others

What the payments were for

  • Food & beverage$631100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$631 in reported general payments places this provider in the 50th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$24,289
Medicare patients
108
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$68,926
JanuviaSitagliptin Phosphate11$14,015
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,351
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$2,558
Fluticasone Propionate66$1,254
Albuterol Sulfate HfaAlbuterol Sulfate50$930
Gabapentin65$648
Pantoprazole Sodium92$556
Levocetirizine Dihydrochloride20$443
Levothyroxine Sodium56$440
Citalopram HbrCitalopram Hydrobromide12$367
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$364
Ropinirole Hcl18$346
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst26$344
Amlodipine Besylate85$343

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere$48$8,35113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,610 family providers in Louisiana.

Other family in Houma

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →